| Application no. and date | 07842260.7 (espacenet) (Federated) (European Patent Register), 20070911 | | Patent/reg. no. and date | DK/EP 2073810, 20110831 | | Publication date | 20090701 | | Priority no. and date | WO PCT/US2006/003595, 20060913, WO PCT/US2006/035958, 20060913, US 894628 P, 20070313 | | EP pub. no. and date |
EP 2073810 20090701 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome
Chuo-ku
Osaka- shi, Osaka 541-0045, JP | | Applicant ref. no. | 155180 | | Inventor | COVINGTON, Paul, 3116 Braemar Lane
Wilmington, North Carolina 28409, US,
CHRISTOPHER, Ronald J., 1059 Snipe Court
Carlsbad, CA 92011, US,
OGAWA, Atsushi, Takeda Pharmaceutical Company Limited
17-85, Jusohonmachi 2-chome
Yodogawa-ku
Osaka 532-8686, JP | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61P 3/10 (2006.01) , A61P 31/18 (2006.01) , A61P 35/00 (2006.01) , A61P 5/50 (2006.01) | | Title | Anvendelse af 2-6-(3-aminio-piperidin-l-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-l-ylmethyl-4-fluor-benzonitril til behandling af diabetes, cancer, autoimmune sygdomme og HIV infektion | | Int. application no. | US2007078177 | | Int. publication no. | WO2008033851 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
